BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Talineuren readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Talineuren\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06431971-1663@assetmemo.bio
DTSTAMP:20261121T005658Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Talineuren: Phase 2 readout est. (NCT06431971)
DESCRIPTION:Talineuren\, phase 2\, Parkinson's Disease.\nStudy: Estimates o
 f the Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson 
 Disease\nEstimated primary completion: December 2027. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/talineuren#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT06431971
URL:https://assetmemo.bio/drug/talineuren#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
